Brigatinib-analog - CAS# 1197958-12-5 60061 J Pharm Belg

J Pharm Belg

CUDC-101 displays broad antiproliferative activity in many human cancer cell types with IC50 of 0

1021/cn300183k

CADTH Canadian Drug Expert Committee Recommendation: Obeticholic Acid (Ocaliva — Intercept Pharmaceuticals Canada): Indication: Primary biliary cholangitis [Internet]

Molecular Weight: 282

Brigatinib-analog - CAS# 1197958-12-5 60061 J Pharm BelgBrigatinib analog, CAS No. 1197958 12 5, is an orally active, potent and selective anaplastic lymphoma kinase (ALK) and the epidermal growth factor receptor (EGFR) inhibitor. Brigatinib analog is structurally related to Brigatinib (AP 26113). Brigatinib analog binds to and inhibits ALK kinase and ALK fusion proteins as well as EGFR and mutant forms. This leads to the inhibition of ALK kinase and EGFR kinase, disrupts their signaling pathways and